secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001641489-24-000045
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics stockholders elect seven directors and approve 2024 Equity Incentive Plan
--------------------------------------------------------------------------------

- At the June 11, 2024 annual meeting, stockholders elected Srinivas Akkaraju, Raymond Cheong, Fahed Al Marzooqi, Richard Nelson, Anne Phillips, Paul Sekhri, and Daniel Spiegelman as directors.
- Stockholders approved the 2024 Equity Incentive Plan with 1,814,842 votes for, 103,928 against, and 1,925 abstentions.
- Ernst & Young LLP was ratified as independent auditor for fiscal 2024 with 2,106,193 votes for, 9,580 against, and 99,191 abstentions.
- All director nominees received between 1,887,098 and 1,913,689 votes for, with 294,269 broker non-votes each.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000045/0001641489-24-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000045/vtvt-20240611.htm
  HTML page:      https://secwatch.observer/filing/0001641489-24-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer